clonidine has been researched along with dronabinol in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (14.81) | 18.7374 |
| 1990's | 5 (18.52) | 18.2507 |
| 2000's | 10 (37.04) | 29.6817 |
| 2010's | 7 (25.93) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Daskalopoulos, N; Laubie, M; Schmitt, H | 1 |
| Dalterio, S; de Paolo, L; Peluso, J; Steger, R | 1 |
| Hopkins, GA | 1 |
| Hermans, AJ; Innemee, HC; van Zwieten, PA | 1 |
| Mechoulam, R; Ovadia, H; Weidenfeld, J; Wohlman, A | 1 |
| Griffin, G; Pertwee, RG | 1 |
| Dallaporta, M; Himmi, T; Orsini, JC; Perrin, J | 1 |
| Fernando, SR; Pertwee, RG | 1 |
| Jentsch, JD; Katz, Z; Roth, RH; Wise, A | 1 |
| Bar-Ilan, A; Beilin, M; Belkin, M; Green, K; Neumann, R | 1 |
| Baillie, G; Pertwee, RG; Price, MR; Ross, RA; Stevenson, LA; Thomas, A; Wease, KN | 1 |
| Gessa, GL; Melis, M; Muntoni, AL; Perra, S; Pillolla, G; Pistis, M | 1 |
| Comer, SD; Foltin, RW; Haney, M; Hart, CL; Reed, SC; Vosburg, SK | 1 |
| McMahon, LR; Stewart, JL | 1 |
| Bisaga, A; Brooks, D; Carpenter, KM; Choi, JC; Dakwar, E; Glass, A; Levin, FR; Mahony, A; Mariani, JJ; Nunes, EV; Pavlicova, M; Sullivan, MA | 1 |
| Álvarez-Ossorio, L; Haupts, M; Jonas, A; Vila, C; Witte, K | 1 |
| Comi, G; Gold, R; Hartung, HP; Montalban, X; Otero-Romero, S; Sastre-Garriga, J; Soelberg Sørensen, P; Thompson, AJ; Vermersch, P | 1 |
| Brezing, CA; Brooks, D; Choi, CJ; Levin, FR; Mahony, AL; Mariani, JJ; Pavlicova, M | 1 |
| Jones, É; Vlachou, S | 1 |
4 review(s) available for clonidine and dronabinol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug treatment of glaucoma.
Topics: Acetazolamide; Administration, Topical; Adrenergic beta-Antagonists; Bromocriptine; Clonidine; Dronabinol; Epinephrine; Glaucoma; Humans; Labetalol; Miotics; Nadolol; Parasympathomimetics; Pilocarpine; Propanolamines; Sympathomimetics; Timolol | 1984 |
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Topics: Amines; Analgesics; Baclofen; Cannabidiol; Clonidine; Cyclohexanecarboxylic Acids; Dantrolene; Diazepam; Dronabinol; Drug Combinations; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Injections, Spinal; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Phenol | 2016 |
A Critical Review of the Role of the Cannabinoid Compounds Δ
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Baclofen; Cannabidiol; Clinical Trials as Topic; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Approval; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Multiple Sclerosis; Spinal Cord; Treatment Outcome; United States; United States Food and Drug Administration | 2020 |
4 trial(s) available for clonidine and dronabinol
| Article | Year |
|---|---|
Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse.
Topics: Adrenergic alpha-Agonists; Adult; Affect; Appetite; Attention; Cannabinoids; Clonidine; Double-Blind Method; Dronabinol; Drug Therapy, Combination; Humans; Male; Marijuana Abuse; Mental Recall; Psychomotor Performance; Psychotropic Drugs; Secondary Prevention; Sleep; Substance Withdrawal Syndrome | 2008 |
Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Cannabinoid Receptor Agonists; Clonidine; Craving; Double-Blind Method; Dronabinol; Female; Humans; Male; Marijuana Abuse; Medication Adherence; Middle Aged; Narcotic Antagonists; Secondary Prevention; Substance Withdrawal Syndrome | 2016 |
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Topics: Adult; Baclofen; Cannabidiol; Clonidine; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Plant Extracts | 2016 |
Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment-seekers with cannabis use disorder.
Topics: Adult; Clonidine; Double-Blind Method; Dronabinol; Female; Humans; Male; Marijuana Abuse; Marijuana Smoking; Middle Aged; Motivation; Narcotic Antagonists; Quality of Life; Sex Factors; Smoking Reduction; Surveys and Questionnaires; Temperance; Treatment Outcome | 2018 |
19 other study(ies) available for clonidine and dronabinol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Action of delta 9 tetrahydrocannabinol on the central cardiovascular regulation : mechanism and localization].
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cannabis; Cardiovascular System; Cats; Clonidine; Dogs; Dronabinol; Electric Stimulation; Evoked Potentials; Fentanyl; Heart Rate; Hypothalamus; Medulla Oblongata; Morphine Derivatives; Nalorphine; Naloxone; Sciatic Nerve; Splanchnic Nerves; Spleen | 1975 |
Acute delta 9-tetrahydrocannabinol exposure: effects on hypothalamic-pituitary-testicular activity in mice.
Topics: Animals; Chorionic Gonadotropin; Clonidine; Dronabinol; Ethanol; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Male; Median Eminence; Mice; Mice, Inbred Strains; Norepinephrine; Pituitary Gland; Testis; Testosterone | 1987 |
The influence of delta 9-tetrahydrocannabinol on intraocular pressure in the anaesthetized cat.
Topics: Animals; Brain Stem; Cats; Clonidine; Dose-Response Relationship, Drug; Dronabinol; Female; Hypotension; Injections, Intra-Arterial; Injections, Intravenous; Intraocular Pressure; Male; Sympathetic Nervous System; Vertebral Artery | 1980 |
Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens.
Topics: Animals; Cannabinoids; Clonidine; Dinoprostone; Dose-Response Relationship, Drug; Dronabinol; Humans; Hypothermia; Interleukin-1; Male; Pyrogens; Rats; Temperature; Time Factors | 1995 |
A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens.
Topics: Adenosine Triphosphate; Animals; Arachidonic Acids; Clonidine; Dose-Response Relationship, Drug; Down-Regulation; Dronabinol; Drug Tolerance; Electric Stimulation; In Vitro Techniques; Injections, Intraperitoneal; Male; Mice; Morphine; Muscle Contraction; Muscle, Smooth; Neuromuscular Junction; Norepinephrine; Receptors, Opioid; Vas Deferens | 1995 |
Neuronal responses to delta 9-tetrahydrocannabinol in the solitary tract nucleus.
Topics: Animals; Biguanides; Clonidine; Dronabinol; Glucose; In Vitro Techniques; Male; Neurons; Rats; Rats, Wistar; Solitary Nucleus | 1996 |
Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist.
Topics: Animals; Arachidonic Acids; Clonidine; Dose-Response Relationship, Drug; Dronabinol; Guinea Pigs; In Vitro Techniques; Intestine, Small; Male; Muscle Contraction; Organophosphonates; Receptors, Cannabinoid; Receptors, Drug | 1997 |
Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Dopamine; Dopamine Uptake Inhibitors; Dronabinol; Guanfacine; Hallucinogens; Male; Nucleus Accumbens; Phencyclidine; Prazosin; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha | 1998 |
Pharmacology of the intraocular pressure (IOP) lowering effect of systemic dexanabinol (HU-211), a non-psychotropic cannabinoid.
Topics: Animals; Aqueous Humor; Blood Pressure; Cannabinoids; Clonidine; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Fluorophotometry; Heart Rate; Injections, Intravenous; Intraocular Pressure; Male; Propranolol; Pupil; Rabbits | 2000 |
Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.
Topics: Animals; Arachidonic Acids; Benzoxazines; Cannabinoids; Cannabis; CHO Cells; Clonidine; Cricetinae; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Male; Mice; Morpholines; Muscle Contraction; Naphthalenes; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Vas Deferens | 2005 |
Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons.
Topics: Action Potentials; Adrenergic alpha-Agonists; Analysis of Variance; Animals; Benzoxazines; Calcium Channel Blockers; Cannabinoids; Clonidine; Dose-Response Relationship, Drug; Dronabinol; Locus Coeruleus; Male; Morpholines; Naphthalenes; Neural Inhibition; Neurons; Norepinephrine; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant | 2006 |
Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.
Topics: Adrenergic Agonists; Animals; Behavior, Animal; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Clonidine; Cyclohexanols; Discrimination, Psychological; Dronabinol; Female; Heart Rate; Macaca mulatta; Male; Morpholines; Motor Activity; Naphthalenes; Piperidines; Pyrazoles; Rimonabant; Substance Withdrawal Syndrome | 2010 |